Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis

Critical Care Medicine

Volumn 42, Issue 1, 2014, Pages 90-96

  Steingrub, Jay S ^a,b   Lagu, Tara ^a,b   Rothberg, Michael B ^c   Nathanson, Brian H ^d   Raghunathan, Karthik ^e   Lindenauer, Peter K ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d OptiStatim LLC   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

mechanical ventilation; mortality; neuromuscular blocking agents; sepsis

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; DOXACURIUM; HYPERTENSIVE FACTOR; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; ROCURONIUM; VECURONIUM;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTINUOUS INFUSION; DATA BASE; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEPSIS; SURVIVAL; UNITED STATES; VENTILATED PATIENT;

EID: 84891550113     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31829eb7c9     Document Type: Article

References (24)

1. Arroliga A, Frutos-Vivar F, Hall J, et al; International Mechanical Ventilation Study Group: Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005; 128:496-506
2. Mehta S, Burry L, Fischer S, et al; Canadian Critical Care Trials Group: Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006; 34:374-380
3. Murray MJ, Cowen J, DeBlock H, et al; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142-156
4. Latronico N, Fenzi F, Recupero D, et al: Critical illness myopathy and neuropathy. Lancet 1996; 347:1579-1582
5. De Jonghe B, Sharshar T, Lefaucheur JP, et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-2867
6. Forel JM, Roch A, Marin V, et al: Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34:2749-2757
7. Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-1116
8. Slutsky AS: Neuromuscular blocking agents in ARDS. N Engl J Med 2010; 363:1176-1180
9. Kondili E, Prinianakis G, Georgopoulos D: Patient-ventilator interaction. Br J Anaesth 2003; 91:106-119
10. Tobin MJ, Jubran A, Laghi F: Patient-ventilator interaction. Am J Respir Crit Care Med 2001; 163:1059-1063
11. Forel JM, Roch A, Papazian L: Paralytics in critical care: Not always the bad guy. Curr Opin Crit Care 2009; 15:59-66
12. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
13. Suissa S: Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008; 167:492-499
14. Kurth T, Walker AM, Glynn RJ, et al: Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 2006; 163:262-270
15. Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007; 26:734-753
16. Lin DY, Psaty BM, Kronmal RA: Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998; 54:948-963
17. Chiburis RC, Das J, Lokshin M: A Practical Comparison of the Bivariate Probit and Linear IV Estimators. World Bank Policy Research Working Paper No. 5601 [Internet]. March 1, 2011. Available at: http://papers. ssrn.com/sol3/papers.cfmabstract-id=1792259. Accessed June 15, 2011
18. Rhoney DH, Murry KR: National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit. Pediatr Crit Care Med 2002; 3:129-133
19. Samuelson KA, Larsson S, Lundberg D, et al: Intensive care sedation of mechanically ventilated patients: A national Swedish survey. Intensive Crit Care Nurs 2003; 19:350-362
20. McClellan M, McNeil BJ, Newhouse JP: Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality Analysis using instrumental variables. JAMA 1994; 272:859-866
21. Wang PS, Schneeweiss S, Avorn J, et al: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353:2335-2341
22. Stukel TA, Fisher ES, Wennberg DE, et al: Analysis of observational studies in the presence of treatment selection bias: Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297:278-285
23. Brookhart MA, Rassen JA, Schneeweiss S: Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010; 19:537-554
24. Lagu T, Lindenauer PK, Rothberg MB, et al: Development and validation of a model that uses enhanced administrative data to predict mortality in patients with sepsis. Crit Care Med 2011; 39:2425-2430